CETP and metabolic syndrome: The main research topics during this period were focused on reducing atherosclerotic risk, pharmacology clinical trials, cardiovascular risk, raising HDL-C, lipoprotein testing, cholesteryl ester transfer protein, and metabolic syndrome, among others.